The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research
Abstract Background Ovarian cancer (OC) remains one of the most challenging and deadly malignancies facing women today. While PARP inhibitors (PARPis) have transformed the treatment landscape for women with advanced OC, many patients will relapse and the PARPi-resistant setting is an area of unmet m...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2024-08-01
|
| Serier: | Molecular Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12943-024-02073-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
